Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mr Prasanna Sooriakumaran has been honoured by the Prostate Cancer Foundation (PCF) with a 2015 Young Investigator Award during the 22nd Annual Scientific Retreat in Washington, held 8-10 October.

Prostate Cancer Foundation awards 19 new Young Investigators at PCF’s 22nd Annual Scientific Retreat to accelerate prostate cancer research breakthroughs.
Prostate Cancer Foundation awards 19 new Young Investigators at PCF’s 22nd Annual Scientific Retreat to accelerate prostate cancer research breakthroughs.

PCF Young Investigator Awards, worth $225,000 each, are made to exceptional early career scientists who will pioneer and transform new biotechnologies into saving lives of prostate cancer patients.

Mr Sooriakumaran is a Senior Clinical Researcher in Robotic Surgery & Urology at the Nuffield Department of Surgical Sciences and is mentored by Head of Department Professor Freddie Hamdy.

His successful project proposal ‘Improving Quality of Care for Men with Skeletal Metastases from Prostate Cancer: Defining the Burden-of-Treatment and its Management, and Developing Models to Predict Quality-of-Life’ demonstrates potential for high impact research that will improve the lives of all men with prostate cancer in the near future.

As life expectancy rises, greater numbers of older men with skeletal metastases from prostate cancer suffer higher treatment burdens. The current standard-of-care, androgen deprivation therapy (ADT), causes morbidity and might pose significant damage to bone and mental health. Better definition of burden-of-treatment from ADT will enable appropriate multi-disciplinary management and directly improve quality of care.

Mr Sooriakumaran is exploring an approach to the management of advanced, metastatic prostate cancer without compromising quality-of-life. He will launch a three-year observational study of 200 men with mCRPC to assess a model considering severity of bone lesions, age, anxiety and depression symptoms, co-morbidities, and treatment choices. Testing this model may lead to a predictive tool to guide clinicians in selecting personalized treatment.

Commenting on his success, Mr Sooriakumaran said: 'I am humbled to be the first British urologist to win this prestigious award. It will enable patient-focused research into metastatic prostate cancer and improve treatment stratification. The award will also further my clinical research career in prostate cancer, and I am incredibly grateful to PCF for their support.'

19 awardees were selected this year from a pool of 107 applicants from 65 institutions in nine countries. To date, PCF has provided funding to 172 young investigators, representing a total investment of over $36.5 million.

Read more about the Prostate Cancer Foundation Awards

Similar stories

EndoNET randomises first patient of 2023

A trial investigating how effective endocrine treatment is, prior to surgery in post-menopausal women with breast cancer, has randomised its first patient of the year.

Sheraz Markar awarded Associate Professor title

We are very pleased to announce that Sheraz Markar has been awarded the title of Associate Professor by the University of Oxford.

New Associate Professor at NDS

The Nuffield Department of Surgical Sciences (NDS) is very happy to report that Joanna Hester has been promoted to Associate Professor.

Blog posts

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.